Conversely, down-regulation of MAP3K2 and MAP3K3 in CRC, as seen in GC, may lead to dysregulation of apoptosis, cell cycle control, and immune responses, contributing to tumor development and aggressiveness. The gene discussed is MAP3K3; the disease is colorectal carcinoma.